Method for treatment of dyslipidemia in humans

Details Method for treatment of dyslipidemia in humans Method for treatment of dyslipidemia in humans

1987-11-30

1988-11-29

Myers, Albert T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ortho-hydroxybenzoic acid or derivative doai

514824, A61K 31615

Patent

active

047881836

ABSTRACT:
A method for treating dyslipidemia in a human is disclosed, the dyslipidemia is characterized by an HDL serum cholesterol level of below about 50 milligrams per deciliter. The method consists of the administration to said human of a therapeutically effective amount of 5-{(R)-1-hydroxy-2-[(R)-(1-methyl-3-phenylpropy)amino]-ethyl}salicylamide, 5-{(S)-1-hydroxy-2-[(R)-(1-methyl-3- phenylpropyl)amino]ethyl}salicylamide or a pharmaceutically acceptable salt thereof or a mixture thereof.

REFERENCES:
patent: 4012444 (1977-03-01), Lunts et al.
patent: 4658060 (1987-04-01), Gold et al.

Affiliated with

Also associated with

Rating

Method for treatment of dyslipidemia in humans does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treatment of dyslipidemia in humans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of dyslipidemia in humans will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-363578